• Kyodo

  • SHARE

Astellas Pharma Inc. said Monday it will acquire a full stake in Belgian clinical-stage drug-discovery firm Ogeda SA for up to €800 million ($854 million).

The purchase is part of the Tokyo-based pharmaceutical company’s strategy to strengthen its long-term growth by buying out firms with high-level expertise in research and development.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW